BLFS 24.11 ▼ -2.59% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    BioLife Solutions Inc.

    NASDAQ: BLFS · Real-Time Price · USD
    24.11
    -0.64 (-2.59%)
    At close: Sep 24, 2025, 3:59 PM
    24.11
    0.00%
    After-hours: Sep 24, 2025, 04:10 PM EDT
    -2.59%
    Bid 20.51
    Market Cap 1.15B
    Revenue (ttm) 102.65M
    Net Income (ttm) -5.53M
    EPS (ttm) -0.4
    PE Ratio (ttm) -60.27
    Forward PE 210.67
    Analyst Buy
    Dividends n/a
    Ask 25.18
    Volume 416,261
    Avg. Volume (20D) 499,403
    Open 24.70
    Previous Close 24.75
    Day's Range 23.89 - 24.70
    52-Week Range 19.10 - 29.55
    Beta 1.78
    Ex-Dividend Date n/a

    About BLFS

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol BLFS
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for BLFS stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    BioLife Solutions Inc. is scheduled to release its earnings on Nov 11, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    +9.88%
    BioLife Solutions shares are trading higher after ... Unlock content with Pro Subscription
    news image

    3 weeks ago · zacks.com

    Does BioLife Solutions (BLFS) Have the Potential to Rally 25.6% as Wall Street Analysts Expect?

    The consensus price target hints at a 25.6% upside potential for BioLife Solutions (BLFS). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings...

    news image

    1 month ago · zacks.com

    4 Medical Product Stocks to Watch From a Challenging Industry

    The Zacks Medical products industry sees steady demand, but tariffs & policy headwinds keep growth under pressure in 2025. NVST, BLFS, INFU and MRMD reflect the favorable fundamentals.

    news image

    1 month ago · zacks.com

    BioLife Solutions (BLFS) Upgraded to Strong Buy: Here's Why

    BioLife Solutions (BLFS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

    news image

    1 month ago · zacks.com

    Wall Street Analysts Predict a 39.92% Upside in BioLife Solutions (BLFS): Here's What You Should Know

    The mean of analysts' price targets for BioLife Solutions (BLFS) points to a 39.9% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement amon...

    news image

    1 month ago · seekingalpha.com

    BioLife Solutions, Inc. (BLFS) Q2 2025 Earnings Call Transcript

    BioLife Solutions, Inc. (NASDAQ:BLFS ) Q2 2025 Earnings Conference Call August 7, 2025 4:30 PM ET Company Participants Roderick de Greef - CEO & Chairman Troy Wichterman - Chief Financial Officer Conf...

    news image

    1 month ago · zacks.com

    BioLife Solutions, Inc. (BLFS) Reports Break-Even Earnings for Q2

    BioLife Solutions, Inc. (BLFS) reported break-even quarterly earnings per share versus the Zacks Consensus Estimate of a loss of $0.02. This compares to a loss of $0.06 per share a year ago.

    Add to Watchlist